Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginGross MarginInterest Coverage RatioInventory AverageInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Biofrontera (BFRIW) Equity Average (2020 - 2025)

Biofrontera has reported Equity Average over the past 6 years, most recently at $3.9 million for Q4 2025.

  • Quarterly results put Equity Average at $3.9 million for Q4 2025, down 20.72% from a year ago — trailing twelve months through Dec 2025 was $3.9 million (down 20.72% YoY), and the annual figure for FY2025 was $7.5 million, up 61.64%.
  • Equity Average for Q4 2025 was $3.9 million at Biofrontera, up from -$3.6 million in the prior quarter.
  • Over the last five years, Equity Average for BFRIW hit a ceiling of $23.2 million in Q4 2022 and a floor of -$9.4 million in Q3 2021.
  • Median Equity Average over the past 5 years was $4.0 million (2021), compared with a mean of $6.1 million.
  • Biggest five-year swings in Equity Average: soared 3641.79% in 2022 and later plummeted 175.85% in 2025.
  • Biofrontera's Equity Average stood at -$3.0 million in 2021, then skyrocketed by 869.17% to $23.2 million in 2022, then plummeted by 87.45% to $2.9 million in 2023, then soared by 70.86% to $5.0 million in 2024, then fell by 20.72% to $3.9 million in 2025.
  • The last three reported values for Equity Average were $3.9 million (Q4 2025), -$3.6 million (Q3 2025), and -$2.1 million (Q2 2025) per Business Quant data.